Company Organization

Our Team

AM BioTech has recruited elite teams from the fields of stem cell research, medicine, management, and medical engineering. We gather our strength to develop medicines and medical aesthetic products that are beneficial to human health.

Richard Shieh
Chairman Of The Board／CEO

  • Chairman of China Health Promotion Association
  • He has won more than 30 outstanding awards, including Gusu Leading Talent in Mainland China, Outstanding Mainland Taiwanese Businessman Award, China Chronic Disease Management & Prevention Gold Award, and Outstanding Enterprise Leader Golden Front Award.
  • Former General Manager and Deputy General Manager of Taiwan Branch of the world’s top 100 companies, such as EDS, Hewlett-Packard, Oracle, etc.
    He developed more than ten patents related to medical engineering.
  • He holds a Ph.D. in social medicine and medical business management from Nanjing University in China; a master’s degree in business administration from National Taiwan University in Taiwan; a master’s degree in computer science from the George Washington University in the United States, and further studies at the London Business School in the United Kingdom.

Zan-Shou Wang
Co-Founder / Director

  • Business management
  • New venture investment management
  • Domestic and overseas investment and entrepreneurship IPO listing
  • Successfully listed a company founded by self-investment
    ✓ Mingyi Technology Co., Ltd. (3060)
    ✓ Zhaoli Technology Co., Ltd. (3548)
    ✓ Uni Steel is listed in Singapore
    ✓ Fuliwang Company is listed in China

Dr. Yu-Tang Chin
Director of R&D and Manufacture

  •  Engaged in cancer research, oral stem cell, and exosome research for more than ten years
  • Postdoctoral research at Taipei Medical University, National Defense Medical Center, and Wanfang Hospital
  • More than 40 academic papers related to stem cells and exosomes
  • Holds a Ph.D. from the Institute of Life Sciences, National Defense Medical Center

Ryan Lee
Vice president

  • Participated in the research and development of multiple new drug products CMC
  • PhytoHealth® /Executive Yuan of Agriculture’s Plant Extraction of New Drug Raw Materials Tissue Culture and GAP Cultivation Research Project
  • PhytoHealth® / PG2 Economics Department industry experts quickly review clinical trial plans
  • PhytoHealth® / PDC-748 Economics Ministry SBIR R&D Alliance Plan
  • PhytoHealth® / PG2 Lyo Leading Product Plan of the Industrial Bureau of the Ministry of Economic Affairs

Ariel Huang
Project Director

  • 15 years of experience in a world-renowned CRO company (Pan Global Institute of Pharmacology), serving as Anti-infective supervisor
  • Led the team to pass ISO17025 certification
  • She once served as special assistant and project manager of startup biotechnology company, leading 11 projects such as product production and development, marketing project execution, and fund-raising plans

Dr. herb wu
R&D consultant

  • Ph.D., Biochemistry, University of Maryland, USA
  • Chairman of Taiwan Bio Industry Organization
  • Former CEO of Development Center for Biotechnology 
  • He successfully led the Biotechnology Center to sign a professional antibody entrustment service contract with the international pharmaceutical company Amgen, making it a key partner in the global industrial supply chain

Project Operations Team

DR. YEH,TSU-TE
Tri-Service General Hospital

DR. CHIANG,CHIEN-PING
Tri-Service General Hospital

DR. Chiu,Hsien-Chung
Tri-Service General Hospital

DR. Fu,E
Taipei Tzu Chi Hospital

DR. ZHANG,FANG-WEI
Tri-Service General Hospital

DR. Chiang,Cheng-Yang
Tri-Service General Hospital

DR. Wang,Chih-Hung
Taipei Veterans General Hospital, Taoyuan Branch

DR. Chen,Min-Huey
National Taiwan University Hospital